Juliet Thompson to join Advanced Medical Solutions as non-executive director

WINSFORD, UK - Advanced Medical (TASE:BLWV) Solutions Group plc (AIM:AMS (VIE:AMS2)) announced Monday that Juliet Thompson will be appointed as a non-executive director and chair of the audit committee following the company’s annual general meeting on June 30.

Thompson brings over 30 years of finance, banking and board experience with significant focus in the healthcare sector. She previously served as audit committee chair at Vectura Group Limited and worked as an investment banker advising pharmaceutical and medtech companies.

Currently, Thompson serves as a non-executive director and audit committee chair at Indivior plc, Novacyt (EPA:ALNOV) S.A., and Organox Limited. She holds a BSc in Economics from the University of Bristol and is a qualified chartered accountant.

"I have followed AMS progress over the last few years and am excited to be joining the Board as the company continues its growth journey," Thompson said in the press release statement.

Following her appointment, Thompson will immediately assume the role of audit committee chair and join the nomination and remuneration committees at AMS, a company specializing in tissue-healing technologies.

Grahame Cook, Chair of AMS, said Thompson’s wealth of board experience, particularly in healthcare companies, and her proven track record as an audit committee chair will make her "a valuable addition to our Board."

Advanced Medical Solutions develops and manufactures tissue-healing technology, including tissue adhesives, sutures, haemostats, and wound care dressings. The company markets products under several brands including LiquiBand, RESORBA, and ActivHeal.

The information about the directorate change was disclosed in accordance with the AIM Rules for Companies.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.